Description
Levonaze-O — Dual-Action Antimicrobial Coverage for Comprehensive Infection Management
Levonaze-O combines Levofloxacin 250 mg with Ornidazole 500 mg, pairing a broad-spectrum fluoroquinolone antibiotic with an antiprotozoal and antianaerobic agent in a single tablet. Levofloxacin works against a wide range of aerobic bacterial pathogens, while Ornidazole specifically targets anaerobic bacteria and protozoal organisms, giving physicians combined coverage for mixed infections that single-agent therapy often can’t fully address. This dual-action approach makes Levonaze-O particularly relevant for gastro-intestinal, gynaecological and surgical site infections where both aerobic and anaerobic pathogens are commonly involved, giving franchise partners a genuinely versatile anti-infective combination for their portfolio.
Combination Reliability Backed by Certified Manufacturing
Lxir Medilabs is an ISO and WHO-GMP certified pharmaceutical company headquartered in Panchkula, Haryana with manufacturing carried out at our Baddi, Himachal Pradesh facility. Combining a fluoroquinolone with an antiprotozoal agent in one tablet requires precise formulation to keep both actives stable and consistently bioavailable and Levonaze-O is manufactured under strict quality control to maintain this reliability across every batch. For a PCD pharma franchise company in India, offering a well-formulated dual-action antimicrobial gives field partners a strong product to introduce to general surgeons, gynaecologists and physicians managing mixed bacterial infections.
Product Highlights for Franchise Partners
- Composition: Levofloxacin 250 mg + Ornidazole 500 mg
- Dosage Form: Tablets
- Pack Size: 10 X 10
- Pack Type: ALU ALU for enhanced stability and shelf protection
- Key Benefit: Advanced dual-action antimicrobial support for comprehensive infection management
- Suited For: Distributors and medical representatives expanding their anti-infective range
Franchise partners looking to add a dual-action antimicrobial combination to their portfolio can explore this and other formulations through our PCD pharma franchise division, with complete promotional support.
Disclaimer: This is a prescription antibiotic and should be used strictly under the supervision of a registered medical practitioner.
